The ability of TOX3 to upregulate a number of genes implicated in breast cancer or mammary gland development, including TBX3 [21], BMP7 [22,23], and IL17RB [24], was confirmed by qRT-PCR in transiently transfected cells under estrogen-depleted conditions (Figure 4B). This evidence concerns the gene IL17RB and breast carcinoma.